XT
ABVC icon

XTX Topco’s ABVC BioPharma ABVC Stock Holding History

XTX Topco’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.3K Buy
+48,276
New +$60.1K ﹤0.01% 3608
2026
Q1 		– Sell
-11,261
Closed -$24K – 3776
2025
Q4 		$24K Sell
11,261
-13,540
-55% -$36.3K ﹤0.01% 3022
2025
Q3 		$75.4K Sell
24,801
-27,824
-53% -$85.5K ﹤0.01% 2080
2025
Q2 		$117K Sell
52,625
-7,814
-13% -$10.6K ﹤0.01% 1851
2025
Q1 		$64.1K Buy
60,439
+26,034
+76% +$15.8K ﹤0.01% 1957
2024
Q4 		$20.3K Buy
34,405
+11,000
+47% +$6.14K ﹤0.01% 2038
2024
Q3 		$16K Buy
23,405
+4,461
+24% +$3.22K ﹤0.01% 1876
2024
Q2 		$14.7K Buy
+18,944
New +$19.5K ﹤0.01% 1652

Other funds holding ABVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco's ABVC Position: Q2 2026 in Review

XTX Topco opened a new position in ABVC BioPharma (ABVC) in Q2 2026: 48,276 shares worth $76.3K. The stake represents ﹤0.01% of the portfolio and ranks #3608 among its holdings. This is a return to the name: XTX Topco previously reported a position in ABVC as recently as Q4 2025.

XTX Topco first reported a position in ABVC in Q2 2024 and has held it in 8 quarters since. The position peaked at $117K in Q2 2025. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

  • XTX Topco held 48,276 shares of ABVC BioPharma worth $76.3K as of Q2 2026.
  • ABVC BioPharma was a new XTX Topco position in Q2 2026.
  • ABVC BioPharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3608 holding.
  • XTX Topco first reported a position in ABVC BioPharma in Q2 2024 and has held it in 8 quarters since.
  • XTX Topco's ABVC BioPharma position peaked at $117K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.